Dwarfism Clinical Trial
Official title:
A Phase 3 Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
This study aims to evaluate the efficacy and safety of recombinant human growth hormone injection in short stature children due to chronic kidney disease before transplantation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01157793 -
A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
|
Phase 4 | |
| Completed |
NCT00001190 -
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
|
Phase 2 | |
| Active, not recruiting |
NCT03255694 -
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
|
Phase 2 | |
| Recruiting |
NCT03221088 -
A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
|
Phase 2 | |
| Completed |
NCT00234533 -
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
|
Phase 3 | |
| Completed |
NCT00001754 -
Study of Skeletal Disorders and Short Stature
|
N/A | |
| Recruiting |
NCT03635580 -
Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS
|
Phase 3 | |
| Completed |
NCT00001343 -
The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
|
Phase 2 | |
| Completed |
NCT00001536 -
Issues Surrounding Prenatal Genetic Testing for Achondroplasia
|
N/A |